Registry for people living with sarcoidosis
Official title: Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
Run by Foundation for Sarcoidosis Research · NCT06234384 · Data updated 2026-11-12
This study is collecting health information from people with sarcoidosis to better understand the condition and help future research.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years and up |
| Sex | All |
| Enrollment | 6833 (estimated) |
| Sponsor | Foundation for Sarcoidosis Research Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | July 2013 |
| Main results expected | June 2033 |
| Study ends | July 2033 |
| Registry record updated | September 19, 2025 |
| Trial ID | NCT06234384 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are English-speaking individuals who have been diagnosed with sarcoidosis.
✕Probably not a fit
Patients who do not speak English or do not have a diagnosis of sarcoidosis will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a longitudinal registry that collects patient-reported outcomes from individuals diagnosed with sarcoidosis. Participants will provide information on demographics, disease symptoms, their diagnostic journey, treatment experiences, and the overall burden of the disease while ensuring their privacy is maintained. The registry will facilitate a better understanding of sarcoidosis and support future research efforts by documenting the natural history of the condition. Participants can voluntarily update their health information annually and may opt out at any time.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of sarcoidosis and improve patient care and treatment options.
How similar studies have gone: Other observational studies have successfully utilized patient registries to improve understanding and treatment of chronic conditions, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. English speaking 2. Consent 3. Sarcoidosi diagnosis - Exclusion Criteria: NONE
Where it's running
-
Foundation For Sarcoidosis Research
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Leslie Serhuck, MD MA Mbioethics
- Email: info@stopsarcoidosis.org
- Phone: 312-341-0500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two prednisolone tapering plans for people with stable sarcoidosis
The team will try two different prednisolone tapering plans to see if people with stable sarcoidosis taking 5–10 mg/day can safely cut their dose by at least half.
-
Immune cells in lung disease and how they could guide immunotherapy
This project sees if immune cell profiling from blood can explain why people with lung cancer, sarcoidosis, or COPD respond differently to immunotherapy or develop chronic lung inflammation.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Virtual groups to reduce sarcoidosis-related fatigue
This project tests whether an 8-week virtual Mindfulness-Based Stress Reduction (MBSR) program can help reduce fatigue and improve anxiety and depression in adults with sarcoidosis compared with a monthly virtual support group.
-
Counting and classifying inflammatory cells in uveitis with OCT
This project will try to use high-resolution OCT scans to count and categorize inflammatory cells and proteins in people with anterior uveitis and related eye inflammation.
-
Comparing yoga and physiotherapy for sarcoidosis treatment
This study is testing whether yoga or traditional physiotherapy helps people with sarcoidosis improve their lung function and feel better overall.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.